Bioscript Group enhances its medical writing and scientific content creation by acquiring Enzyme Communications
Bioscript Group expands its medical writing, scientific content, and storytelling capabilities with the acquisition of science communication experts, Enzyme Communications.
Bioscript Group, a leading provider of medical communications, market access, and regulatory writing services, has announced the acquisition of science communication experts, Enzyme Communications.
Enzyme Communications, a science communications agency, is known for its innovative approaches to scientific storytelling, bringing a new dimension to the Bioscript Group by providing expertise in building scientific stories from data and helping clients effectively articulate how their products change lives.
The addition of Enzyme Communications enhances the Bioscript Group’s expertise in complex diseases, adding specialist knowledge in oncology and rare diseases. They also bring a wealth of experience in strategy and planning, creativity, and content production.
The Enzyme Communications team will sit within the medical and scientific communications division of the Bioscript Group and will continue to be led by co-founders Neil Kumar and Adam Goodband.
Gabrielle Silver, CEO of Bioscript Group, said: “Enzyme Communications is a very welcome addition to our portfolio as we continue our journey to become leaders in scientific communications for the life sciences sector.
“The synergies between our two organisations are clear. Enzyme’s distinctive approach to strategic planning and scientific storytelling bolsters the group’s capabilities and will help our clients think even more creatively about how to define their scientific proposition across target audiences.”
Enzyme Communications’ co-founder and client services director, Neil Kumar, said: “Enzyme was built on the foundations of quality, creativity, and authenticity and we recognise these same values in the Bioscript Group.
“Joining the Bioscript Group not only allows us to scale and enhance the services we currently offer to our clients, it also brings new opportunities for growth and development for our talented team. We can’t wait to see them thrive and progress in this partnership.”
Science Communication Director and Co-founder Adam Goodband highlighted “Ultimately, we are a team of people who get excited about working on cutting-edge science and repackaging it in ways that are strategically relevant, creative, and new. In Bioscript Group, we recognise those shared passions, and complement each other’s skills set which will enhance our offerings to existing clients on both sides.”
The acquisition of Enzyme Communications by Bioscript Group represents a significant step for both organizations and shows the growing importance of science communication in the life sciences sector.
